Phage display technology: clinical applications and recent innovations.
about
Mimotope vaccination--from allergy to cancerPhage display discovery of novel molecular targets in glioblastoma-initiating cellsSimvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 ProteinRecognition of Salmonella Typhimurium by Immobilized Phage P22 Monolayers.A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant proteinA novel strategy for rapid construction of libraries of full-length antibodies highly expressed on mammalian cell surfaces.Identification of peptide ligands for target RNA structures derived from the HIV-1 packaging signal psi by screening phage-displayed peptide libraries.Selection of peptides inhibiting a beta-lactamase-like activity.Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Screening phage display libraries for organ-specific vascular immunotargeting in vivoPanning and identification of a colon tumor binding peptide from a phage display peptide library.An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.Employing phage display to study the mode of action of Bacillus thuringiensis Cry toxins.HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.Identification of novel specific allosteric modulators of the glycine receptor using phage display.A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo.Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy.Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin BProduction and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2Molecular considerations for development of phage antibody libraries.Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selectionPhage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.Characterization of the native and denatured herceptin by enzyme linked immunosorbent assay and quartz crystal microbalance using a high-affinity single chain fragment variable recombinant antibody.Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design.TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkersNovel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.In vitro evolution and affinity-maturation with Coliphage qβ displayEGFR-binding peptide: a patent evaluation of WO2014002836.Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.Systems approaches to design of targeted therapeutic delivery.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisImprovement and efficient display of Bacillus thuringiensis toxins on M13 phages and ribosomesClassification epitopes in groups based on their protein family.Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display TechnologyBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.
P2860
Q24608624-9063603B-6829-454A-8082-ECA71E5CE991Q28240138-6FA0E2F6-4147-44BA-A786-ECB560FF8EA0Q28550067-4BCF55CF-0DDA-40E3-9216-A9B33C7B2158Q30489648-CBF467C6-DEDD-422F-96BC-73A31313A100Q30938718-49EB3690-27CB-48DF-A7BB-0C24D685985FQ30987126-33816313-B912-4FA4-B554-A24452808F10Q31005300-EC1980E1-1B3F-4738-A1CC-E1D63BC95B89Q33187520-D1A0C80D-2C68-464E-855E-9277044662D5Q33218208-EE3A55B1-3F96-480A-A8F3-FCE72344DE9BQ33230098-E39FAC6F-BDC9-4CDC-8D44-3ACCBF89B0CEQ33230544-D491BF59-D0E8-41FD-AFDE-9F422A340975Q33276355-3C41ACF8-7A81-4D5A-BCAF-095FB9705D71Q33288077-FAEBEB7B-2374-408F-94F2-252D29CD3245Q33316888-E29D427B-F06C-4973-9F06-288504A8388BQ33479955-945EEF63-E6CB-408A-A930-9D6AA6A40F4FQ33551911-1E3886CC-EDD1-4630-AAEC-77B43AECFA11Q33587125-D00C576E-6B2F-4CB7-95CA-6E2BCBBA7DCDQ33647707-D2DBFB7F-9635-468A-A6E8-A01AAE5F1E15Q33679580-6913148C-7F09-461D-A254-19BF8447FB92Q33720576-081B3BDB-7CA9-4BE6-B421-A1C152D64795Q33997700-7BF666B5-A0B7-4507-9A5F-591B971AF39FQ34032165-DC757612-E40C-4C01-9641-6CC334EE5C69Q34089704-7DB3A47A-4BC3-4EC2-BF65-286340DFB02AQ34226542-D173AFBC-2673-46B6-A229-B1B8449A8CA4Q34273411-82A9657F-EF07-4573-B12D-EDF4604E26B5Q34287677-028A3E3A-CCB2-4E14-8F90-13610C4369AFQ34385892-DF2D8893-9FC4-4C61-B847-AA4F7F8FF740Q34398068-08507A57-7CD9-4967-AAA7-8A59F2193208Q34419541-B7DC293C-CF1A-4D1A-ACDC-9509EA75E778Q34566316-D28A37F2-F18E-4143-93BF-8ECDDE7EE863Q35389145-7B8A4691-51F0-409A-BB58-7276C73581A2Q35418618-28B6DAF8-52F3-4D5E-8A15-6FBBD44F2063Q35433987-D1CD569B-603B-440E-84C8-B293D7904C20Q35606494-D447CC13-388D-4EEC-8BFF-876A653ECDECQ35623160-886BEEC6-B39C-45D3-BDFD-91145DF1C108Q35710262-D4C38EBE-3806-44DC-9C41-1460F32ADD2EQ35852780-68740C9D-E29F-4A24-BA66-F028D5E6C815Q35876192-674295FA-14D4-4C14-B249-00E4AE09C97CQ35899838-B69A2557-154E-4376-846C-944454826F51Q35963673-BE8087D6-AF1E-476B-A38D-505D155F584C
P2860
Phage display technology: clinical applications and recent innovations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phage display technology: clinical applications and recent innovations.
@ast
Phage display technology: clinical applications and recent innovations.
@en
type
label
Phage display technology: clinical applications and recent innovations.
@ast
Phage display technology: clinical applications and recent innovations.
@en
prefLabel
Phage display technology: clinical applications and recent innovations.
@ast
Phage display technology: clinical applications and recent innovations.
@en
P1476
Phage display technology: clinical applications and recent innovations.
@en
P2093
Hassan M E Azzazy
W Edward Highsmith
P304
P356
10.1016/S0009-9120(02)00343-0
P577
2002-09-01T00:00:00Z